A Brief introduction on the Challenges and Strategies in Antibody Drug Production
A Brief introduction on the Challenges and Strategies in Antibody Drug Production No content available
NewsRoom
Chime Biologics won two awards at the Asia Pacific Biologics CMO Excellence Awards 2024
Chime Biologics won two awards at the Asia Pacific Biologics CMO Excellence Awards 2024 Recently, at the 3rd Biologics Contract Manufacturing Asia held in Singapore, Chime Biologics was honored with two prestigious awards at the Asia Pacific Biologics CMO Excellence Awards (APBCEA) 2024 — “Best CDMO Award of the Year” and “Best Biologics CMO Award: […]
pilot-plant-of-chime-biologics
pilot-plant-of-chime-biologics No content available
Key Points in the Implementation of Biopharmaceutical Technology Transfer
Key Points in the Implementation of Biopharmaceutical Technology Transfer No content available
Going Global – Chime Biologics Embraces Innovation and Quality with Partners
Going Global-Chime Biologics Embraces Innovation and Quality with Partners Foreign biopharmaceutical companies seek CDMO partners with long-term prospects, technology levels, and quality systems aligned with international standards. Jimmy Wei, President of Chime Biologics, highlighted that the company’s competitive edge arises from ensuring product quality, leveraging efficiencies, and maintaining stringent cost controls. July 5, 2024, Shanghai, […]
CHO Cell Line Development: Process and Key Technical Points Overview
CHO Cell Line Development: Process and Key Technical Points Overview No content available
(中文) 生物类似药中美欧法规速递
Sorry, this entry is only available in 中文. For the sake of viewer convenience, the content is shown below in the alternative language. You may click the link to switch the active language.